FibroBiologics, Inc. Common Stock (FBLG) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for FibroBiologics, Inc. Common Stock, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.54x | -5.89x | -57.36x | -184.55x | -597.40x | -808.83x |
| P/B Ratio | 1.63x | 24.04x | 754.60x | -236.51x | -732.63x | 0.00x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 3.61x | 1.12x | 1.00x | 0.37x | 0.27x | 0.00x |
| Quick Ratio | 3.61x | 1.12x | 1.00x | 0.37x | 0.27x | 0.00x |
| Leverage | ||||||
| Debt/Equity | 0.39x | 3.86x | 1.39x | -1.88x | -1.01x | 0.00x |
YoY = year-over-year change. Source: FMP..